Global Biopharmaceuticals Market by Product Type, by Therapeutic Application and by Geography – Opportunities & Forecast, 2018-2025
Biopharmaceuticals Market by Product Type (Monoclonal Antibody, Interferon, Insulin, Growth Factor, Erythropoietin, Vaccine, Hormone And Others), by Therapeutic Application (Oncology, Blood Disorder, Metabolic Disease, Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology and Others) and by Geography
1. Executive Summary
2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Geographical Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology
3. Global Biopharmaceuticals Market - Overview
3.1. Introduction
3.2. Market Segmentation
3.3. Pipeline Analysis
3.4. Drivers
3.5. Restraints
3.6. Trends
4. Global Biopharmaceuticals Market Revenue Forecast till 2025
5. Global Biopharmaceuticals Market by Product Type Revenue Forecast till 2025
5.1. Monoclonal antibody
5.2. Interferon
5.3. Insulin
5.4. Growth factor
5.5. Erythropoietin
5.6. Vaccine
5.7. Hormone
5.8. Others
6. Global Biopharmaceuticals Market by Therapeutic Application Revenue Forecast till 2025
6.1. Oncology
6.2. Blood disorder
6.3. Metabolic disease
6.4. Infectious disease
6.5. Cardiovascular disease
6.6. Neurological disease
6.7. Immunology
6.8. Others
7. Global Biopharmaceuticals Market by Geography Revenue Forecast till 2025
7.1. North America Biopharmaceuticals Market Revenue Forecast till 2025
7.1.1. North America Biopharmaceuticals Market by Product Type (Option 1: 25% customization)
7.1.1.1. Monoclonal antibody
7.1.1.2. Interferon
7.1.1.3. Insulin
7.1.1.4. Growth factor
7.1.1.5. Erythropoietin
7.1.1.6. Vaccine
7.1.1.7. Hormone
7.1.1.8. Others
7.1.2. North America Biopharmaceuticals Market by Therapeutic Application
7.1.2.1. Oncology
7.1.2.2. Blood disorder
7.1.2.3. Metabolic disease
7.1.2.4. Infectious disease
7.1.2.5. Cardiovascular disease
7.1.2.6. Neurological disease
7.1.2.7. Immunology
7.1.2.8. Others
7.2. Europe Biopharmaceuticals Market Revenue Forecast till 2025
7.2.1. Europe Biopharmaceuticals Market by Product Type (Option 2: 25% customization)
7.2.1.1. Monoclonal antibody
7.2.1.2. Interferon
7.2.1.3. Insulin
7.2.1.4. Growth factor
7.2.1.5. Erythropoietin
7.2.1.6. Vaccine
7.2.1.7. Hormone
7.2.1.8. Others
7.2.2. Europe Biopharmaceuticals Market by Therapeutic Application
7.2.2.1. Oncology
7.2.2.2. Blood disorder
7.2.2.3. Metabolic disease
7.2.2.4. Infectious disease
7.2.2.5. Cardiovascular disease
7.2.2.6. Neurological disease
7.2.2.7. Immunology
7.2.2.8. Others
7.3. Asia-Pacific Biopharmaceuticals Market Revenue Forecast till 2025
7.3.1. Asia-Pacific Biopharmaceuticals Market by Product Type (Option 3: 25% customization)
7.3.1.1. Monoclonal antibody
7.3.1.2. Interferon
7.3.1.3. Insulin
7.3.1.4. Growth factor
7.3.1.5. Erythropoietin
7.3.1.6. Vaccine
7.3.1.7. Hormone
7.3.1.8. Others
7.3.2. Asia-Pacific Biopharmaceuticals Market by Therapeutic Application
7.3.2.1. Oncology
7.3.2.2. Blood disorder
7.3.2.3. Metabolic disease
7.3.2.4. Infectious disease
7.3.2.5. Cardiovascular disease
7.3.2.6. Neurological disease
7.3.2.7. Immunology
7.3.2.8. Others
7.4. Rest of the World Biopharmaceuticals Market Revenue Forecast till 2025
7.4.1. Rest of the World Biopharmaceuticals Market by Product Type (Option 4: 25% customization)
7.4.1.1. Monoclonal antibody
7.4.1.2. Interferon
7.4.1.3. Insulin
7.4.1.4. Growth factor
7.4.1.5. Erythropoietin
7.4.1.6. Vaccine
7.4.1.7. Hormone
7.4.1.8. Others
7.4.2. Rest of the World Biopharmaceuticals Market by Therapeutic Application
7.4.2.1. Oncology
7.4.2.2. Blood disorder
7.4.2.3. Metabolic disease
7.4.2.4. Infectious disease
7.4.2.5. Cardiovascular disease
7.4.2.6. Neurological disease
7.4.2.7. Immunology
7.4.2.8. Others
8. Competitive Landscape
8.1. Industry Attractiveness
8.2. Porter 5 Analysis
8.3. Major players and their key strategies
8.4. Company Share Analysis
9. Company Profiles (Option 5: 25% Customization - Profiles of 5 Additional Companies of your Choice)
9.1. Sanofi
9.1.1. Company Overview
9.1.2. Financials
9.1.3. Recent Developments
9.2. F. Hoffmann-La Roche
9.2.1. Company Overview
9.2.2. Financials
9.2.3. Recent Developments
9.3. AbbVie Inc.
9.3.1. Company Overview
9.3.2. Financials
9.3.3. Recent Developments
9.4. Pfizer, Inc.
9.4.1. Company Overview
9.4.2. Financials
9.4.3. Recent Developments
9.5. Merck & Co., Inc.
9.5.1. Company Overview
9.5.2. Financials
9.5.3. Recent Developments
9.6. Novartis AG
9.6.1. Company Overview
9.6.2. Financials
9.6.3. Recent Developments
9.7. Johnson & Johnson
9.7.1. Company Overview
9.7.2. Financials
9.7.3. Recent Developments
9.8. GlaxoSmithKline
9.8.1. Company Overview
9.8.2. Financials
9.8.3. Recent Developments
9.9. Eli Lilly and Company
9.9.1. Company Overview
9.9.2. Financials
9.9.3. Recent Developments
9.10. AstraZeneca PLC,
9.10.1. Company Overview
9.10.2. Financials
9.10.3. Recent Developments
10. About GMI Research
- Published Date: Feb-2020
- Report Format: Excel/PPT
- Report Code: HM45A-00-0719
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
Global Biopharmaceuticals Market by Product Type, by Therapeutic Application and by Geography – Opportunities & Forecast, 2018-2025
$ 4,499.00 – $ 6,649.00
Why GMI Research
